# Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia

Study · id `cardio:ct-nct03218865` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03218865](<https://clinicaltrials.gov/study/NCT03218865>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03218865

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT03218865. Randomized; no masking; primary purpose treatment. Start 2013-10-16 (actual); primary completion 2018-06-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT03218865, source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)
- Started: 2013-10-16 (actual) (ClinicalTrials.gov record NCT03218865, source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)
- Primary completion: 2018-06-24 (actual) (ClinicalTrials.gov record NCT03218865, source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)
- Completion: 2018-12-24 (actual) (ClinicalTrials.gov record NCT03218865, source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT03218865, source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03218865-2019-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia
- Acronym: EVIA
- Condition: End Stage Renal Disease
- Condition: Inflammation
- Intervention (Device): VIE high flux dialyzer
- Intervention (Device): Leoceed H high flux dialyzer
- Lead sponsor: Hemotech
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 6152e13c37df54d861b5cc1920292bcd6f7a41b17276f12079c6d88e12212e18
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
